Vaccinia virus produces two different infectious forms, intracellular mature virus (IMV) and extracellular enveloped virus (EEV
Introduction
The final steps in the replication cycle of vaccinia virus include the assembly and maturation of the two infectious forms. Intracellular mature virus (IMV) is assembled in specialized areas in the cytoplasm by a complex process which is poorly understood. A proportion of IMV is wrapped by vesicles derived from the trans-Golgi network (TGN), or endosomal membranes, thereby acquiring two additional membranes to form intracellular enveloped virus (IEV) (Hiller & Weber, 1985 ; Schmelz et al., 1994 ; Tooze et al., 1993) . These virions migrate to the cell periphery, where their outermost membrane fuses with the plasma membrane, thus liberating enveloped virions into the extracellular space. Enveloped virions, which contain an additional membrane with respect to IMV, may remain cell-associated (CEV) or be released in the extracellular space (EEV). IMV and EEV are antigenically distinct and seem to play different biological roles. EEV has been shown to be important in long-distance spread of infectious virus in vitro and in vivo, and is also relevant in terms of pathogenicity (Payne, 1980) . P37 is the major protein in the external envelope of EEV (Hiller & Weber, 1985 ; Payne, 1978) , and is tightly bound to the inner surface of the outer membrane (Roos et al., 1996 ; Schmutz et al., 1995) . Within infected cells, P37 is localized in the Golgi region, associated with vesicles which form doublewalled envelopes around IMV (Hiller & Weber, 1985) . It has been shown that P37 plays a crucial role in this envelopment process and the subsequent release of enveloped virus (Blasco & Moss, 1991 Schmutz et al., 1991) . In cells infected with P37 − mutants, in which 93 % of the F13L gene has been deleted (Blasco & Moss, 1991 , no association of IMV particles with Golgi membranes is detected and formation of EEV is severely diminished. P37 − viruses are also unable to form plaques under standard conditions, proving that P37 is required for efficient cell-to-cell transmission. Strict correlation between virus envelopment and plaque formation suggests that virus transmission is carried out by enveloped virus, either EEV or CEV.
P37 is a 372 aa protein encoded by vaccinia virus open reading frame (ORF) F13L (Hirt et al., 1986) . It is an acylated protein (Child & Hruby, 1992) and it has been recently shown that cysteine residues at positions 185 and 186 are both modified by palmitate (Grosenbach et al., 1997) . The palmitate moiety is responsible for the hydrophobic nature of the protein (Grosenbach et al., 1997 ; Schmutz et al., 1995) , mediates its membrane interaction and therefore directs its correct intracellular location. Palmitylation is crucial for function, since non-palmitylated versions of the protein, i.e. proteins in which the cysteine acceptor residues have been mutated, are not functional (Grosenbach & Hruby, 1998 ; Grosenbach et al., 1997) . We are interested in P37 because of its role in the morphogenesis and function of EEV. In addition, P37 − mutants, as well as other viruses with mutated EEV envelope proteins, are attenuated and might be of use as safe vaccine vectors. Complementing cell lines facilitate work with the corresponding mutant viruses and, in addition, offer an opportunity to study a given viral protein out of the infection context. In the present report, we describe such a cell line and study the complementation of the characteristics affected by P37 deletion : release of EEV and plaque-forming ability. Furthermore, we demonstrate that P37 produced in this cell line differs from P37 produced during virus infection.
Methods
Cells, viruses and antibodies. Green African monkey kidney cell line CV-1 and rabbit kidney cell line RK-13 were obtained from the ATCC and grown routinely in Eagle's minimum essential medium (EMEM) supplemented with 5 % foetal bovine serum (FBS), 2 mM glutamine, and 100 U\ml and 100 µg\ml penicillin and streptomycin, respectively.
Vaccinia viruses WR and IHD-J, and their respective mutants which lack the F13L gene, vRB12 and vRB10 (called W-P37 − and I-P37 − in this report), have been previously described (Blasco & Moss, 1991 . Virus infections were carried out according to standard procedures for vaccinia viruses (Earl & Moss, 1991) . Stocks of P37 − viruses were obtained by infecting cultures at high m.o.i. to ensure complete infection of the culture. Semi-solid medium used in some plaquing and titration experiments was prepared by mixing equal volumes of complete EMEM 2i and 2 % LMP agarose or 2 % methylcellulose (Sigma). To visualize virus plaques, the monolayers were fixed with 10 % formaldehyde for 15 min and stained with crystal violet.
To obtain extracellular virus, the supernatant of infected cultures was cleared by a short centrifugation ; intracellular virus was obtained by scraping the infected cells in EMEM-2 % FBS, followed by three cycles of freeze-thawing.
Monoclonal antibody 15B6, a rat antibody against protein P37 (Schmelz et al., 1994) , was kindly made available by G. Hiller (Boehringer Mannheim, Germany) and was produced in medium containing RPMI 1640, 20 % FBS, 0n35 % glucose and 0n05 mM β-mercaptoethanol. The antibody was used directly as the hybridoma culture supernatant.
Plasmid construction. The F13L ORF containing an NdeI site at the start and a BamHI site at the end, was amplified by PCR using plasmid pHFR7 (Blasco & Moss, 1991) as a template. The primers were as follows (restriction sites are shown in bold letters ; ATG for P37 is underlined) : 5h AACCATATGTGGCCATTTGCATCGGTACC 3h ; and 3h CATTT-AGCAATTTTTAAATTTCCTAGGAAA 5h.
The PCR product was blunt-ended by Klenow enzyme and subcloned into the SmaI site of pUC19. The resulting plasmid was then digested to obtain the F13L ORF flanked by BamHI sites ; this was then cloned into the BamHI site of eukaryotic expression vector pSG5 (Stratagene) to isolate plasmid pSG-P37. The lack of mutations within the coding sequence was corroborated by sequencing.
Control plasmid pSV-β-gal was obtained from Promega.
Isolation of stably transfected RK-13 cell lines. Monolayers of 10' RK-13 cells in 10 cm tissue culture plates were co-transfected by the calcium phosphate technique with 10 µg pSG-P37 and 1 µg pBSpac∆p, a plasmid conferring resistance to the antibiotic puromycin (De la Luna & Ortin, 1992) . Forty-eight hours after transfection, cells were washed and selections were made by adding selection medium [EMEM-10 % FBS containing 5 µg\ml puromycin (Sigma)]. At 4 day intervals, medium was replaced with fresh selection medium, up to about 2 weeks after transfection. Visible puromycin-resistant cell colonies were picked, transferred into 96-well tissue culture plates and propagated as separate cell clones. A second, independent isolation of stably transfected cells was performed as described above except that 24 h after transfection, cells were trypsinized and transferred to three 10 cm culture plates. Selection was applied at day 3 post-transfection.
Screening of clones was carried out by infection of parallel cultures with vaccinia virus P37 − . Monolayers in 24-well tissue culture plates derived from the cell clones were infected with about 40-50 p.f.u. I-P37 − virus per well. Spread of the infection was monitored and compared with that on RK-13 parental cells. Positive clones were amplified and stored in liquid nitrogen in freezing medium (90 % FBS-10 % DMSO). Some of the clones were subjected to a further characterization. Clone 1D3 was finally selected and will be referred to as RK P$( . The clone was routinely grown in EMEM-5 % FBS containing 2n5 µg\ml puromycin.
Western-ECL immunoblotting.
To obtain cell extracts, monolayers were washed with cold PBS and incubated for 20 min on ice with lysis buffer (50 mM Tris-HCl, pH 8n0, 150 mM NaCl, 2 mM EDTA, 1 % NP-40, 1 µg\ml leupeptine, 1 mM PMSF). Cells were scraped and centrifuged and the supernatant was recovered. Proteins were resolved by electrophoresis in 12 % polyacrylamide-SDS gels and transferred onto nitrocellulose membranes by electroblotting (30 V for 1 h at room temperature). After transfer, the membranes were blocked in PBS buffer containing 5 % non-fat dry milk and then incubated overnight at 4 mC with monoclonal antibody 15B6 (diluted 1 : 10 in PBS containing 1 % nonfat dry milk, 0n05 % Tween 20). After extensive washing with PBS-0n05 % Tween 20, the membranes were incubated for 1 h at room temperature with sheep anti-rat Ig conjugated to horseradish peroxidase (Amersham) diluted 1 : 1000 in PBS-0n05 % Tween 20. After washing, membranes were incubated for 1 min with a 1 : 1 mix of solution A [2n5 mM luminol (Sigma), 0n4 mM p-coumaric acid (Sigma), 100 mM Tris-HCl, pH 8n5] and solution B (0n018 % H # O # , 100 mM Tris-HCl, pH 8n5) and exposed to an autoradiographic film.
Pulse labelling and immunoprecipitation. RK-13 or RK P$( cells in 12-well plates were infected with vaccinia viruses WR and W-P37 − , respectively, at an m.o.i. of 10 p.f.u. per cell. At different times postinfection, the medium was replaced with medium containing 25 µCi\ml TRAN$&SLABEL ([$&S]methionine\[$&S]cysteine ; ICN). At the end of the labelling period, cells were washed once with cold PBS, and lysed by incubation with 50 mM Tris-HCl, pH 7n4, 1 % NP-40, 150 mM NaCl, 2 mM EDTA for 20 min on ice. Lysates were then collected, clarified and immunoprecipitated with antibody to P37. Immunoprecipitation was essentially carried out as described previously (Grosenbach et al., 1997 Vaccinia virus P37 complementing cell line Vaccinia virus P37 complementing cell line Phase partitioning experiments. The hydrophobic nature of P37 was analysed by phase partitioning using Triton X-114 (Bordier, 1981) . Briefly, supernatants of mock-or virus-infected cell cultures were discarded, and cells were scraped in PBS and centrifuged for 10 min at 1500 r.p.m. Pellets were resuspended in a mixture of 1 % Triton X-114, 10 mM Tris-HCl and 150 mM NaCl, incubated in ice for 10 min, mixed and centrifuged ; supernatants were incubated for 5 min at 37 mC. A sample of the total fraction was taken and, after centrifugation, aqueous and detergent fractions were separated. An equal proportion of each fraction was analysed by SDS-PAGE and Western blotting.
Immunofluorescence. Cells grown on round cover-slips were infected at an m.o.i. of 10 p.f.u. per cell. After 6 h infection, cells were washed twice with PBS, fixed for 15 min at room temperature with 4 % paraformaldehyde and permeabilized by incubating for 15 min with PBS containing 0n1 % Triton X-100. After blocking with PBS-20 % horse serum, cover-slips were incubated with monoclonal antibody to P37, washed and incubated with rabbit anti-rat immunoglobulin-FITC (DAKO). Both incubations were carried out at room temperature for 30 min, diluting the antibodies 1 : 50 in PBS-20 % horse serum. Then cover-slips were washed, mounted and observed by fluorescence microscopy.
Results

Isolation of cell lines expressing P37
Vaccinia viruses lacking P37 have a defect in intracellular virus wrapping, resulting in a marked decrease in extracellular virus formation and inefficient cell-to-cell spread (Blasco & Moss, 1991 . As a consequence, P37 − vaccinia viruses do not form plaques on cell culture monolayers under normal plaquing conditions. It is conceivable that a cell line expressing P37 could complement, at least to some extent, the P37 − defect. In order to isolate such a cell line, we constructed plasmid pSG-P37, in which the F13L gene, encoding P37, was placed downstream of the SV40 early promoter. RK-13 cells were co-transfected with pSG-P37 and pBSpac∆p, encoding a puromycin-resistance cassette. After applying puromycin selection, cell clones were grown separately and tested for their ability to propagate P37 − vaccinia virus. In the screening, cell monolayers in 2 cm# culture wells were infected with 50 p.f.u. I-P37 − virus, and subsequently monitored during 2-3 days for the appearance of a generalized cytopathic effect.
The results of two separate transfection experiments are summarized in Table 1 . The first transfection experiment rendered about 200 cell clones that were resistant to puromycin, of which four were selected as positive. A second, independent experiment, yielded 15 positive clones. These results were similar to those obtained when using a plasmid containing the β-galactosidase gene, suggesting that the P37 gene did not have a deleterious effect on the cells. Out of a total of 19 positive clones, three were selected for further analysis. No significant differences in cell growth, P37 − virus plaque formation or protein expression were observed between these clones (data not shown). We therefore selected one clone, which is referred to as RK P$( , for more detailed characterization.
Table 1. Summary of results from transfection experiments
Cell cultures were mock-transfected (no plasmid) or transfected with the plasmid combinations indicated. The amounts used in each transfection were 1 µg pBSpac∆p alone or mixed with 10 µg pSV-β-gal or pSG-P37. 
Expression of P37 in RK P37 cells
P37 expression in RK P$( cells was tested by Western blot analysis using a monoclonal antibody against P37 (Fig. 1 a) . The antibody recognized a protein of about 40 kDa in RK P$( cell extracts, which is similar in size to P37 that is synthesized during infection with wild-type virus. However, the amount of P37 in RK P$( cells was significantly lower than the amount present at late time-points in WR infection. We estimated that RK P$( cells contain 4-to 5-fold less protein than infected cells at 24 h post-infection.
In both RK-13 cells infected with WR and uninfected RK P$( cells, the antibody also recognized a protein of about 27 kDa which curiously was not detected in RK P$( cells infected with W-P37 − . This band was present at variable intensities in different experiments (not shown). We have not further investigated the origin of this polypeptide, which is presumably a proteolytic product of P37.
Vaccinia virus induces a shut-off of host protein synthesis. Since RK P$( cells were constitutively expressing a gene of viral origin, by means of a cellular mRNA, it was of interest to determine whether the protein was being synthesized during infection. We followed the kinetics of P37 expression by RK P$( cells during infection with a vaccinia virus P37 deletion mutant (Fig. 1 b) . In WR-infected cells, P37 expression followed the characteristic kinetics of a viral late protein, in agreement with previous reports (Hiller & Weber, 1985) . In growing RK P$( cells, the protein was also synthesized, albeit at lower levels. Upon infection of RK P$( cells with W-P37 − , synthesis of the protein diminished during infection, indicating that P37 expression was affected by virus-induced shut-off. However, some expression of P37 continued at late time-points, as revealed by continuous labelling at 9-24 h (Fig. 1 b) .
Complementation of P37 N virus by RK P37 cells
P37 is required for the envelopment and subsequent egress of virions. Vaccinia virus strains greatly differ in the amount of extracellular virions released from infected cells. For instance, most enveloped virions in virus strain WR remain associated with the cell membrane and, accordingly, virus titres in the extracellular medium remain low, usually less than 1 % of total virus (Payne, 1979 ; Payne & Kristensson, 1985) . In contrast, enveloped virions in virus strain IHD-J are more readily released from the infected cell and, as a consequence, extracellular virus represents up to 35 % of total virus. Because of the strain differences, deletion of the P37 gene, and therefore the lack of virus envelopment, is better detected as a reduction of plaque size (for the WR strain) or as a decrease in EEV formation (for the IHD-J strain) (Blasco & Moss, 1992) .
To determine the extent to which RK P$( cells complement the P37 deletion, we measured extracellular virus formation by strains WR and IHD-J, and their respective P37 deletion mutants, under one-step growth conditions (Fig. 2) . As expected, cell-associated virus titres were similar in all cases (data not shown). Extracellular virus production by the parental viruses WR and IHD-J was largely unaffected by expression of P37 in RK P$( cells. However, there was a 50-fold increase in extracellular virus formation in I-P37 − -infected cells when the RK P$( cell line was used instead of normal RK-13 cells. Despite this increase, extracellular virus titres did not reach wild-type levels, probably reflecting a limiting amount of P37 under these conditions. The WR-derived deletion mutant, W-P37 − , showed a 2-to 3-fold increase in extracellular virus production in RK P$( cells, reaching a level similar to that of parental WR virus.
Another phenotypic feature of viruses that lack P37 is their inability to form plaques under standard conditions, which has been related to the paucity of enveloped virus produced by these mutant viruses (Blasco & Moss, 1991 . In RK P$( cells, we observed an increase in EEV production by I-P37 − and W-P37 − . We therefore sought to determine whether P37 mutants would be able to form plaques on RK P$( cells (Fig. 3) . As previously reported, P37 deletion mutants do not form plaques under the standard conditions (2 days), and only form tiny plaques after prolonged (7 days) incubation times. Plaque formation was clearly accelerated in RK P$( cells, since small plaques were visible after 3-5 days.
P37 synthesized in RK P37 cells shows altered hydrophobicity and intracellular distribution
In order to characterize the P37 produced by RK P$( cells, we carried out phase partitioning experiments using Triton X-114 (Fig. 4) . Preliminary experiments confirmed that palmityllabelled proteins partitioned exclusively with the detergent phase (not shown). As expected, P37 present during a normal infection partitioned into the detergent phase, a result EDA consistent with the protein being palmitylated. In contrast, P37 in RK P$( cells was distributed in the two phases, indicating that the protein was only partially palmitylated. Interestingly, infection with P37 − virus seemed to promote palmitylation of the protein.
The intracellular distribution of P37 in RK P$( cells was studied by indirect immunofluorescence (Fig. 5) . RK-13 cells infected with WR (Fig. 5 b) displayed a normal pattern of distribution of P37, with strongly stained juxtanuclear areas, which correspond to the Golgi region, and a more peripheral punctuated staining which reveals enveloped virions. Uninfected RK P$( cells (Fig. 5 c) showed some Golgi staining, together with a more diffuse cytoplasmic labelling, and a lack of peripheral staining consistent with the absence of virus particles. As with the Triton X-114 experiments, infection of RK P$( cells with P37 − virus modified the distribution of the protein.
Therefore, our phase partitioning and immunofluorescence results suggest that, in the absence of other virus proteins, palmitylation and localization of P37 occur inefficiently.
Discussion
To date, six virus-encoded proteins have been described as constituents of the envelope of the extracellular form of vaccinia virus. Of these, P37 occupies a unique position in several respects. Besides being the major protein constituent of the envelope, P37 is located in the inner surface of the EEV envelope, in a position to mediate the IMV-membrane interaction required for the wrapping process. In contrast to other EEV envelope proteins, P37 is not a transmembrane protein, but rather it is associated with the membrane via a palmityl fatty acid. Also, P37 plays a central role in virus envelopment, since deletion of the gene results in a strong reduction of virus envelopment and cell transmission. Finally, it has been shown that P37 contains phospholipase motifs (Koonin, 1996 ; Ponting & Kerr, 1996) and has several phospholipase activities (Baek et al., 1997) .
The mutant virus\complementing cell line described in this report demonstrates that it is possible to complement a major structural protein by means of cellular expression. It is of note that the complementation is achieved despite the fact that it involves a viral late function and that cell-directed P37 gene expression is shut off during infection. For other vaccinia virus genes, complementing cell lines have been described in which mutant phenotypes can be corrected by cellular expression of the gene (Holzer & Falkner, 1997 ; Sutter et al., 1994) . These systems deal with early genes, but to our knowledge, this is the first report showing complementation of a defect in a late virus gene.
The hydrophobicity and intracellular localization of the protein was significantly different in RK P$( cells when compared to normal infection. The P37 immunofluorescence staining obtained in RK P$( cells is also consistent with the one obtained by transient expression in COS cells (Katz et al., 1997) . The fact that palmitylation and localization of the protein correlate closely is congruent with previous reports showing that palmitylation is required for proper intracellular targeting of the protein (Grosenbach & Hruby, 1998 ; Grosenbach et al., 1997) . Interestingly in these reports, expression of mutant, non-palmitylated forms of P37 was carried out in vaccinia virus-infected cells. In contrast, our system allowed us to compare P37 in the presence or absence of infection. Detergent phase partitioning (Fig. 4) suggested that palmitylation of P37 occurred, albeit inefficiently, in the absence of infection. In addition, our results suggest that the presence of other virus proteins is required for efficient palmitylation of the protein and proper intracellular targeting. It is likely that protein-protein interactions of P37 with other EEV envelope proteins play a role in these processes.
Besides the use of P37 deletion mutants as tools to improve understanding of the morphogenesis process of vaccinia virus, viruses lacking P37 have other practical uses. An efficient recombinant virus selection system has been developed, in which rescue of plaque formation allows a rapid screening and selection of recombinant plaque-forming viruses (Blasco & Moss, 1995) . In addition, P37 − viruses are severely attenuated (S. Isaacs, R. Blasco & B. Moss, unpublished results), and therefore P37 deletion may increase the safety of recombinant vaccines based on these mutants because of their decreased transmissibility. The use of virus-cell systems like the one described here should facilitate the isolation and further modification of P37 − and similar mutant viruses.
